Webinars and Sponsored Roundtables — Register Now
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The roundtable is made possible by a special educational grant from Pillar Biosciences.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.
Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Illumina.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Product Spotlight
Clinisys/Orchard Software
| Company | Clinisys/Orchard Software |
|---|---|
| Name of laboratory information system | Orchard Enterprise Lab LIS |
| Contact | Beth Eder |
| City, State | Carmel, IN |
| Phone | 800-856-1948 |
| Website | |
| Company provides list of client sites to potential customers on request | yes (partial list of comparable sites with no restrictions regarding its use) |
| Updates covered by standard software maintenance fee | all updates |
| Schedule for providing standard software updates to clients | quarterly |
| Clients must install updates in specified timespans to avoid maintenance fee increase | yes (clients are required to stay within the latest 2 versions to avoid an upgrade fee) |
| Fee for software modifications to comply with federal regulations and laws | no |
| Year company began selling LISs (any brand or model) | 1993 |
| Most recent LIS go-live at a client site (based on August 2025 survey deadline) | Jun-2025 |
| Last product release or update for featured LIS | 100 |
| No. of U.S. sales and installations of LIS between August 2024–July 2025 | 6 sales/6 installations |
| Total No. of U.S. sites operating LIS (hospitals/independent labs/clinics or group practices/public health labs/other sites) | 100 (2/9/60/1/28–universities, drug testing, pain management, COVID, veterinary, virtual, retail) |
| • Approx. percentage of high-vol.* U.S. site installs/Low-vol.** U.S. site installs | 100%/0 |
| Foreign locations where company actively markets LIS for clinical lab use | none |
| • Foreign locations where LIS has been installed for clinical lab use | Canada |
| Human languages (other than English) supported by LIS | none |
| Approximate No. of employees in entire company | 267 |
| Central hardware or service type | HP Business Class |
| Programming languages and development applications or environments | SQL, Java |
| Operating system(s) | Windows Server 2012 R2 SP1, 64 bit or later |
| Databases | Microsoft SQL |
| System includes full transaction logging | yes |
| • Chemistry/Hematology/Print barcoded collection labels | installed at client sites (all 3 features) |
| • Microbiology/Public health microbiology | installed at client sites/installed at client sites |
| • Blood bank donor/Blood bank transfusion | available via Haemonetics/available via Haemonetics |
| • Surgical pathology/Cytology | installed at client sites/installed at client sites |
| • Molecular pathology/Cytogenetics/Flow cytometry | installed at client sites/installed at client sites/installed at client sites |
| • EHR interface for admission/discharge/transfer (ADT) | installed at client sites |
| • EHR interface for order entry/EHR interface for results reporting | installed at client sites/installed at client sites |
| • EHR interface+GQ3:GQ15 for packaging results into PDF format | installed at client sites |
| • EHR interface for packaging results into CDA1 format/CDA2 format | installed at client sites/installed at client sites |
| • Ad hoc reporting/Rules-based system | installed at client sites/installed at client sites |
| • Management and statistical reporting/Client services or CRM module | installed at client sites/available via Orchard Outreach |
| • POL link or Web portal to physician offices/Patient Web portal | available via Orchard Outreach/available via Orchard patient portal |
| • Commercial reference lab functionality/Compliance checking | installed at client sites/installed at client sites |
| • Comprehensive billing and accounts receivable or RCM | • Comprehensive billing and accounts receivable or RCM |
| • Materials management and inventory/Test partition | installed at client sites/installed at client sites |
| • Remote faxing/Remote printing | installed at client sites/installed at client sites |
| • HIPAA-standard transaction formats | installed at client sites |
| • Web-based remote inquiry of reports/Web access for order entry | installed at client sites/installed at client sites |
| • Management and tracking of specimens within lab/Before arriving in lab | installed at client sites/installed at client sites |
| • QA tools/Environmental health | installed at client sites/installed at client sites |
| • Interfaces for sending orders from primary lab to reference lab, handling results return, and status updates | installed at client sites |
| • Business analytics/Clinical analytics | installed at client sites/installed at client sites |
| • Ability to schedule patient for test collection/Patient-based test registration | installed at client sites/not available |
| • Ability to coordinate with nurses for collections that phlebotomists cannot perform | available via Orchard Outreach |
| • Interfaces with public health databases using ELR as part of Promoting Interoperability | installed at client sites |
| • Results for tests run using different methods show method on clinical reports | installed at client sites |
| Barcode symbologies supported by LIS | Codabar (NW-7), Code 39, Code 128, DataMatrix (LIS also supports QR codes) |
| Ability to use artificial intelligence (e.g., machine-learning software) with LIS | planned for future |
| • Microbiology (culture and sensitivity) | yes |
| • Other reportable diseases or conditions (e.g., blood lead, immunology, etc.) | yes (blood lead, immunology, others) |
| • Tumor diagnosis and case data to regional cancer registry*** | yes |
| LIS bidirectionally interfaces to other IT vendors’ lab systems in live sites | yes |
| LIS uses third-party middleware for LIS–instrument interfaces | no (interface directly) |
| Lab automation systems or workcells to which LIS has a direct interface | Beckman Coulter, Siemens, QuidelOrtho, Sysmex, Thermo Scientific, Olympus, Roche, Abbott, Tecan, others |
| LIS supports use of SNOMED CT | yes, for all cases |
| LIS automatically ingests and applies electronic updates of tables and rules from organizations and government agencies | no |
| LIS allows for image capture, display, reporting | yes |
| LIS provides indexed field in each test definition for LOINC code | yes |
| Client gets copy of source code/User group that meets on established schedule | escrow/no |
| Qualified users or third parties can modify or augment LIS functions or features | yes (client users) |
| Methods by which users can tailor LIS in their own setting | ad hoc query tools, user-defined interfaces, dictionary settings, read/write privileges, workflow configuration, tailored worklists, user-defined security, others |
| Distinguishing product features (supplied by company) | expert interfacing and integration with instruments, EMR and host systems, departments, reference labs; robust rules-based decision support logic and data-mining technology for data analytics; advanced data mining allows labs to track key performance metrics and quality assurance measures |
| Notes | — |